DiaSorin Receive Clearance for LIAISON® CMV and EBV Assays

DiaSorin Inc. have recently received FDA clearance for their LIAISON® Cytomegalovirus assays, including CMV IgG/CMV IgM and Epstein-Barr Virus assays, including VCA IgM, VCA IgG and EBNA IgG

The LIAISON® analyser combines a flexible operating mode with a broad assay menu and leads to high efficiency due to its long walk-away time. The possibility to run up to 15 different assays at a time provides for rational everyday testing even for low numbers of samples. Moreover, a throughput of up to 180 determination per hour allows LIAISON® to cope easily with a very high volume of samples. It is easy to use due to its touch-screen monitor, clear software structure and the Reagent Integral which contains all assay-specific reagents.

"Flash" chemiluminescence detection system
Paramagnetic microparticle solid phase
Sample and reagent continuous loading
Random access or batch mode
2-point calibration
Maximum through put: ~180 results/h

NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source : DiaSorin Inc. [USA] View archived contact details
Is a subsidiary/distributor for
DiaSorin S.p.A., Italy View Company Information

Posted on July 25, 2005